Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3105104
Max Phase: Preclinical
Molecular Formula: C27H30Cl2O6
Molecular Weight: 521.44
Molecule Type: Small molecule
Associated Items:
ID: ALA3105104
Max Phase: Preclinical
Molecular Formula: C27H30Cl2O6
Molecular Weight: 521.44
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]2(O)[C@H]1OC(=O)c1c(Cl)cccc1Cl)[C@H]1[C@@H](C[C@H]3C)C1(C)C
Standard InChI: InChI=1S/C27H30Cl2O6/c1-12-10-26-13(2)8-16-20(25(16,3)4)15(22(26)32)9-14(11-30)21(31)27(26,34)23(12)35-24(33)19-17(28)6-5-7-18(19)29/h5-7,9-10,13,15-16,20-21,23,30-31,34H,8,11H2,1-4H3/t13-,15+,16-,20+,21-,23+,26+,27+/m1/s1
Standard InChI Key: WCRDBPZZXRNSOP-VZNJPERDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 521.44 | Molecular Weight (Monoisotopic): 520.1419 | AlogP: 3.99 | #Rotatable Bonds: 3 |
Polar Surface Area: 104.06 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.13 | CX Basic pKa: | CX LogP: 4.00 | CX LogD: 4.00 |
Aromatic Rings: 1 | Heavy Atoms: 35 | QED Weighted: 0.41 | Np Likeness Score: 2.46 |
1. Grue-Sørensen G, Liang X, Månsson K, Vedsø P, Dahl Sørensen M, Soor A, Stahlhut M, Bertelsen M, Engell KM, Högberg T.. (2014) Synthesis, biological evaluation and SAR of 3-benzoates of ingenol for treatment of actinic keratosis and non-melanoma skin cancer., 24 (1): [PMID:24332494] [10.1016/j.bmcl.2013.11.073] |
Source(1):